Matthew C. Hill
Chief Financial Officer · Apyx Medical Corp
Individual
- 2025
- Jun 15, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Matthew C. Hill's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Matthew Gline - $46.17M in ROIV purchases and sales in the last 12 months
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew C. Hill?
Matthew C. Hill is a corporate insider, tracked as Chief Financial Officer of Apyx Medical Corp (APYX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Matthew C. Hill last file a Form 4?
The most recent primary Form 4 on record is dated 15 June 2026, one of 2 filings going back to 2025.